Treatment of Children and Adolescents With Growth Failure Associated With Primary IGF-1 Deficiency
- 24 Juillet 2024 - 1 mn de lecture
This is an extension study to Tercica study MS301 (NCT00125164) and is intended to collect long term safety and efficacy data on the continued use of recombinant human insulin-like growth factor-1 (rh IGF-1) in children and adolescents treated for primary IGF-1 deficiency (IGFD). The secondary objective is to use the data collected to learn more about the relationship of IGF-1 exposure to the promotion of normal growth and pubertal development.
24 Juillet 2024
1 mn de lecture
A study to evaluate the effect of phenytoin or itraconazole on the circulating levels of IPN60130 in healthy adult participants
24 Juillet 2024
1 mn de lecture
A Rollover Study to Further Evaluate the Safety and Efficacy of Palovarotene Capsules in Male and Female Participants Aged ?14 Years With Fibrodysplasia Ossificans Progressiva...
24 Juillet 2024
1 mn de lecture
A study to assess whether adding maintenance cabozantinib (XL184) to best supportive care helps children, adolescents and young adults with osteosarcoma.
24 Juillet 2024
2 mn de lecture
A study to evaluate the effectiveness and safety of Dysport® for the prevention of episodic migraine in adults
24 Juillet 2024
2 mn de lecture
A study to evaluate the effectiveness and safety of Dysport® for the prevention of chronic migraine in adults
24 Juillet 2024
1 mn de lecture
A Study to Compare the Safety and Efficacy of Dysport® and Botox® in Adults With Upper Limb Spasticity.
24 Juillet 2024
2 mn de lecture
A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours
24 Juillet 2024
2 mn de lecture
Efficacy and Safety of Lanreotide Autogel/ Depot 120 mg vs. Placebo in Subjects With Lung Neuroendocrine Tumours
24 Juillet 2024
1 mn de lecture
Long Term Safety And Effectiveness Of Dysport® In Adults With Cervical Dystonia
24 Juillet 2024
1 mn de lecture